FIELD: medicine.
SUBSTANCE: peritoneal dialysate contains 0.05 to 3.5 wt/vol % of taurine and 0.1 to 6.5 wt/vol % of trehalose as osmotic agents and exhibiting a pH value regulated between 6.5 to 7.5.
EFFECT: invention provides safe and high-stable peritoneal dialysate which does not induce peritoneal membrane disorders, peritoneal sclerosis accompanying recurrent peritoneal-dialysis therapy, can protect residual renal functions in chronic renal insufficiency and delayed progression of renal injury for a long period of time, enabled peritoneal-dialysis therapy in a diabetic patient.
33 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
PERITONEAL THERAPEUTIC LIQUID | 2016 |
|
RU2718908C2 |
BIOCOMPATIBLE AQUEOUS SOLUTION FOR PERFORMING CONTINUOUS PERITONEAL AMBULATORY DIALYSIS | 1996 |
|
RU2158593C2 |
CARBOHYDRATE COMPOSITIONS FOR DIALYSIS | 2018 |
|
RU2749443C2 |
SOLUTION FOR PERITONEAL DIALYSIS | 2014 |
|
RU2567043C1 |
WATER FOR OBTAINING DIALYSING SOLUTION, DIALYSING SOLUTION WITH SAID WATER APPLICATION, METHODS OF OBTAINING DIALYSING SOLUTION AND DEVICE FOR DIALYSIS | 2006 |
|
RU2396218C2 |
PERITONEAL DIALYSIS METHOD | 2003 |
|
RU2353400C2 |
SORBENT FOR DIALYSIS DEVICE AND DIALYSIS SYSTEM | 2017 |
|
RU2785326C2 |
PHARMACEUTICAL COMPOSITION FOR PERITONEAL DIALYSIS | 1992 |
|
RU2118531C1 |
COMPOSITIONS AND METHODS FOR REINTEGRATION OF SOLUTION FOR MULTIPLE DIALYSIS CONTAINING ALBUMIN CARRIER PROTEIN | 2017 |
|
RU2754045C2 |
ACID DIALYSIS CONCENTRATE | 2013 |
|
RU2568846C2 |
Authors
Dates
2011-09-27—Published
2007-08-15—Filed